Year |
Citation |
Score |
2017 |
Lin E, Rivera-Báez L, Fouladdel S, Yoon HJ, Guthrie S, Wieger J, Deol Y, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S. High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells. Cell Systems. PMID 28941584 DOI: 10.1016/J.Cels.2017.08.012 |
0.483 |
|
2016 |
Paholak HJ, Stevers NO, Chen H, Burnett JP, He M, Korkaya H, McDermott SP, Deol Y, Clouthier SG, Luther T, Li Q, Wicha MS, Sun D. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy. Biomaterials. 104: 145-157. PMID 27450902 DOI: 10.1016/J.Biomaterials.2016.06.045 |
0.554 |
|
2016 |
Chen YC, Zhang Z, Fouladdel S, Deol Y, Ingram PN, McDermott SP, Azizi E, Wicha MS, Yoon E. Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells. Lab On a Chip. PMID 27381658 DOI: 10.1039/C6Lc00062B |
0.463 |
|
2016 |
Lin E, Rivera L, Fouladdel S, Yoon HJ, Guthrie S, Weiner J, Deol YS, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S. Abstract 3307: Label-free high throughput microfluidic device for the isolation and single cell multiplex gene expression analysis of circulating tumor cells from breast cancer patients Cancer Research. 76: 3307-3307. DOI: 10.1158/1538-7445.Am2016-3307 |
0.507 |
|
2015 |
Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, Nasser MW, Ganju RK. Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Molecular Cancer. 14: 195. PMID 26573004 DOI: 10.1186/S12943-015-0451-9 |
0.632 |
|
2015 |
Nie S, McDermott SP, Deol Y, Tan Z, Wicha MS, Lubman DM. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations. Proteomics. PMID 26332018 DOI: 10.1002/Pmic.201500002 |
0.503 |
|
2015 |
Luo M, Clouthier SG, Deol Y, Liu S, Nagrath S, Azizi E, Wicha MS. Breast cancer stem cells: current advances and clinical implications. Methods in Molecular Biology (Clifton, N.J.). 1293: 1-49. PMID 26040679 DOI: 10.1007/978-1-4939-2519-3_1 |
0.628 |
|
2015 |
Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, Nasser MW, Ganju RK. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Molecular Cancer. 14: 11. PMID 25622979 DOI: 10.1186/S12943-014-0275-Z |
0.701 |
|
2015 |
Fouladdel S, Yoon HJ, Lin E, Kim TH, Deol YS, Luther TK, Clouthier SG, Jiang H, Burness ML, Nagrath S, Azizi E, Wicha MS. Abstract 4726: Gene expression signatures of isolated circulating tumor cells from metastatic breast cancer patients reveal presence of breast cancer stem cells with EMT or MET phenotypes Cancer Research. 75: 4726-4726. DOI: 10.1158/1538-7445.Am2015-4726 |
0.601 |
|
2015 |
Deol YS, McDermott SP, Lubman DM, Chang JC, Nie S, Luther TK, Cong Y, Azizi E, Colacino J, Clouthier SG, Wicha M. Abstract 2220: Annexin A3 regulates MET-like aldehyde dehydrogenase positive breast cancer stem cells Cancer Research. 75: 2220-2220. DOI: 10.1158/1538-7445.Am2015-2220 |
0.646 |
|
2015 |
Lin E, Rivera L, Yoon HJ, Fouladdel S, Wieger J, Guthrie S, Deol YS, Clouthier SG, Luther TK, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S. Abstract 1593: Label-free high throughput microfluidic device for the isolation of circulating tumor cells from breast cancer patients Cancer Research. 75: 1593-1593. DOI: 10.1158/1538-7445.Am2015-1593 |
0.505 |
|
2014 |
Fouladdel S, Yoon HJ, Kim TH, Shi A, Luther T, Hayden J, Clouthier SG, Deol YS, Burness ML, Hayes DF, Nagrath S, Azizi E, Wicha MS. Abstract 4828: Circulating tumor cells (CTCs) isolated from patients with metastatic breast cancer utilizing a sensitive microfluidic graphene oxide (GO) nanosheet device express markers of cancer stem cells Cancer Research. 74: 4828-4828. DOI: 10.1158/1538-7445.Am2014-4828 |
0.583 |
|
2014 |
Azizi E, Fouladdel S, Deol YS, Bender J, McDermott S, Jiang H, Sehl M, Clouthier SG, Nagrath S, Wicha MS. Abstract 1943: Exploring cancer stem cells heterogeneity via single cell multiplex gene expression analysis Cancer Research. 74: 1943-1943. DOI: 10.1158/1538-7445.Am2014-1943 |
0.541 |
|
2013 |
Sneh A, Deol YS, Ganju A, Shilo K, Rosol TJ, Nasser MW, Ganju RK. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling. Breast Cancer Research and Treatment. 138: 727-39. PMID 23535840 DOI: 10.1007/S10549-013-2491-4 |
0.709 |
|
2012 |
Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Research. 72: 604-15. PMID 22158945 DOI: 10.1158/0008-5472.Can-11-0669 |
0.726 |
|
2012 |
Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Shilo K, Wolf R, Yuspa SH, Ganju RK. Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages Cancer Research. 72: 388-388. DOI: 10.1158/1538-7445.Am2012-388 |
0.705 |
|
2011 |
Deol YS, Nasser MW, Yu L, Zou X, Ganju RK. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells. The Journal of Biological Chemistry. 286: 44845-54. PMID 22016394 DOI: 10.1074/Jbc.M111.225466 |
0.739 |
|
2011 |
Nasser MW, Qamri Z, Deol YS, Smith D, Shilo K, Zou X, Ganju RK. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. Plos One. 6: e23901. PMID 21915267 DOI: 10.1371/Journal.Pone.0023901 |
0.668 |
|
2011 |
Nasser MW, Qamri Z, Deol YS, Leone G, Zou X, Wolf R, Yuspa SH, Ganju RK. Abstract 403: Overexpression of S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways Cancer Research. 71: 403-403. DOI: 10.1158/1538-7445.Am2011-403 |
0.722 |
|
2011 |
Deol YS, Nasser MW, Ganju R. Abstract 1024: Tumor suppressive effects of S100A7 are mediated through β-catenin/TCF4 pathway in ERα positive breast cancer Cancer Research. 71: 1024-1024. DOI: 10.1158/1538-7445.Am2011-1024 |
0.704 |
|
2009 |
Anand AR, Prasad A, Bradley RR, Deol YS, Nagaraja T, Ren X, Terwilliger EF, Ganju RK. HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1. Blood. 114: 3588-600. PMID 19700666 DOI: 10.1182/Blood-2009-02-206342 |
0.517 |
|
Show low-probability matches. |